Amgen

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Amgen
TickerAMGN
CIK #0000318154
CUSIP031162100
SectorLife Sciences
IndustryBiological Products, (No Disgnostic Substances)
Phone805313176
AddressOne Amgen Center Drive Mail Stop 24-1-B
Thousand Oaks, CA 91320-1799
Source [EDGAR]
Market Cap, 13F ($BB)
14011284562802011201320152018
Business

Amgen Inc. (including its subsidiaries, referred to as "Amgen," "the Company," "we," "our" or "us") is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Amgen was incorporated in California in 1980 and became a Delaware corporation in 1987. We have a presence in approximately 100 countries worldwide. Amgen operates in one business segment: human therapeutics.

CIK Filing 2011 - 2021
[0000318154] 10-K
[0000318154] 10-Q
[0000318154] 3
[0000318154] 4
[0000318154] 5
[0000318154] 8-K
[0000318154] SC 13D
[0000318154] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Amgen Inc Akero Therapeutics Inc [2020-02-10] 9.0
Amgen Inc Beigene Ltd [2020-01-08] 20.5
Amgen Inc Provention Bio Inc [2019-09-25] 9.0
Amgen Inc Kezar Life Sciences Inc [2019-02-08] 9.0
FMR LLC Amgen Inc [2017-02-14] 0.0
Amgen Inc Advaxis Inc [2016-08-02] 9.0
Amgen Inc Unilife Corp [2016-03-03] 9.0
Amgen Inc Atara Biotherapeutics Inc [2015-04-01] 9.0
Vanguard Group Inc Amgen Inc [2015-02-11] 5.37
Amgen Inc Cytokinetics Inc [2013-06-18] 7.58
Capital Research Global Investors Amgen Inc [2013-02-12] 8.2
FMR LLC Amgen Inc [2012-02-14] 0.0
Amgen Inc Micromet Inc [2012-02-03] 13.2
Form 3/4/5 Filer 2011-2021
Beigene Ltd
Williams R Sanders
Louie Linda H
Reese David M
Kullman Ellen Jamison
Gordon Murdo
Sugar Ronald D
Grygiel Nancy A
Santos Esteban
Miles Amy E
Piacquad David
Patton Cynthia M
Johnston Lori A
Griffith Peter H
Graham Jonathan P
Bradway Robert A
Jacks Tyler
Holley Charles M
Henderson Rebecca M
Hassan Fred
Garland Greg C
Eckert Robert
Druker Brian
Austin Wanda M
Meline David W
Herringer Frank C
Harper Sean E
Kezar Life Sciences Inc
Onyx Therapeutics Inc
Hooper Anthony C
de Carbonnel Francois
Baltimore David
SUCH Annette Louise
McNamee Brian M
Pelham Judith C
Biondi Frank
Tross Stuart A
Balachandran Madhavan
Coffman Vance D
Unilife Corp
Scott David J
Michael A Kelly
Dittrich Thomas JW
Omenn Gilbert S
Amgen Ventures LLC
Tetralogic Pharmaceuticals Corp
Peacock Jonathan M
Epizyme Inc
Schaeffer Leonard D
Reason J Paul
Sharer Kevin W
Richo Anna
Bonanni Fabrizio
Beier David W
Armstrong Acquisition Corp
Micromet Inc
Perlmutter Roger M
MM Shares Owned of 637.2 MM Total
Firm Period DFND Voting Shares
BlackRock Inc. [2020-09-30] SOLE 42.0 48.0
Vanguard Group Inc [2020-09-30] SOLE 0.0 45.2
Capital Research Global Investors [2020-09-30] DFND 33.5 33.5
State Street Corp [2020-09-30] DFND 22.0 31.3
PRIMECAP Management Co/Ca/ [2020-09-30] SOLE 16.9 17.4
FMR LLC [2020-09-30] DFND 1.9 14.2
Geode Capital Management LLC [2020-09-30] DFND 9.1 9.2
Morgan Stanley [2020-09-30] DFND 0.5 8.6
JPMorgan Chase & Co [2020-09-30] DFND 7.6 8.2
Northern Trust Corp [2020-09-30] DFND 2.8 7.7
Wells Fargo & Co/Mn [2020-09-30] DFND 6.8 7.4
Bank of America Corp /DE/ [2020-09-30] DFND 1.5 7.3
Bank of New York Mellon Corp [2020-09-30] DFND 5.7 6.7
Clearbridge Investments LLC [2020-09-30] SOLE 5.8 5.9
Reed Conner & Birdwell LLC [2020-09-30] SOLE 3.2 4.2
Legal & General Group Plc [2020-09-30] DFND 2.8 4.0
Nuveen Asset Management LLC [2020-09-30] DFND 4.0 4.0
Wellington Management Co LLP [2020-09-30] DFND 0.0 3.8
Royal Bank of Canada [2020-09-30] DFND 3.4 3.7
Price T Rowe Associates Inc /MD/ [2020-09-30] SOLE 1.3 3.6
Deutsche Bank AG [2020-09-30] DFND 2.2 3.5
Nordea Investment Management AB [2020-09-30] SOLE 0.2 3.4
Invesco Ltd. [2020-09-30] DFND 0.0 3.2
Capital Research & Management Co - Division 3 [2020-09-30] DFND 3.1 3.1
Parametric Portfolio Associates LLC [2020-09-30] SOLE 2.0 3.0
Sumitomo Mitsui Trust Holdings, Inc. [2020-09-30] DFND 3.0 3.0
Vanguard Group Inc [2020-09-30] DFND 0.0 2.8
Schwab Charles Investment Management Inc [2020-09-30] SOLE 2.8 2.8
LSV Asset Management [2020-09-30] SOLE 1.8 2.7
Dimensional Fund Advisors LP [2020-09-30] DFND 2.4 2.6
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com